Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

noncognitive symptom experienced in patients with dementia. Memantine is a recognized treatment for Alzheimer's disease either alone or in combination with cholinesterase inhibitors. Its efficacy in

agitation
dementia
memantine
cholinesterase
cholinesterase inhibitors
  • 13 views
  • 07 Nov, 2020
  • 1 location
CHIEF PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

has the potential to almost halve the number of falls. This trial aims to definitively determine whether cholinesterase inhibitors (ChEi), can prevent falls in Parkinson's and whether this

dopamine
  • 1 views
  • 23 Jan, 2021
  • 1 location
Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients?

This study will look at the incidence of post-spinal shivering (PSS) among the obstetrics population and will investigate whether higher operation theater (OT) temperature range or/and IV Ondansetron are able to reduce the incidence of PSS. This is a double-blind, randomized, factorial study, patients will be grouped into 4 groups …

  • 0 views
  • 28 Jan, 2021
  • 1 location
tDCS on Parkinson's Disease Cognition

dysfunction is one of the most significant factors affecting the quality of life of patients with PD. While dementia in Parkinson's disease is routinely treated by cholinesterase inhibitors (e.g., donepezil

rivastigmine
motor symptoms
parkinsonism
dementia
brain stimulation
  • 39 views
  • 24 Jan, 2021
  • 1 location
Senolytic Therapy to Modulate Progression of Alzheimer's Disease

The purpose of this pilot study is to evaluate whether a combination of two drugs, dasatinib (D) and quercetin (Q) [D+Q], penetrate the brain using cerebrospinal fluid (CSF) in older adults with early Alzheimer's disease (AD). This combination of drug therapy has been shown to affect dying cells in humans …

dementia
progression of alzheimer's disease
cholinesterase
alzheimer's disease
body mass index
  • 0 views
  • 24 Jan, 2021
  • 1 location